Daniel Dolan

Inga fler pågående positioner

49 år

Health Technology

Consumer Services

Profil

Daniel Dolan worked as Vice President of Financial Planning & Analysis at Radius Health, Inc. from 2020 to 2021.
Prior to that, he worked at Shire Plc as Vice President of Finance Global Product Strategy from 2016 to 2017.
Currently, he is the Chief Financial Officer at Nabriva Therapeutics Plc, a position he started in 2021 and will hold until 2023.
Dolan received his undergraduate degree and MBA from Widener University.

Tidigare kända positioner av Daniel Dolan

Företag	Position	Slut
NABRIVA THERAPEUTICS PLC	Finansdirektör/CFO	2023-06-30
RADIUS HEALTH, INC.	Finansdirektör/CFO	2020-12-15
SHIRE	Företagsledare/Principal	2017-07-01

Se detaljerna i Daniel Dolans erfarenhet

Daniel Dolans utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Daniel Dolans erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	4
Radius Health, Inc. Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics	Health Technology
Shire Plc Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases	Health Technology
Widener University Widener University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nabriva Therapeutics Plc Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents	Health Technology